.svg){kind=small}
Mar-2024
Sales
Trend
6-Month
Product Count
SKUs
Overview
Market Insights Snapshot
In the Topical category within the Arizona market, DermaFreeze has shown a consistent performance over the recent months. The brand maintained its 7th rank from December 2023 through March 2024, indicating a stable position among competitors in this category. While this consistency is commendable, it's noteworthy that the sales figures experienced a dip in January 2024, dropping to $15,160 from December 2023's $22,691. However, the subsequent months saw a gradual recovery in sales, with February 2024 reaching $16,889 and March 2024 slightly higher at $17,188. This rebound suggests resilience and a potential for growth, although the initial drop in sales highlights an area for improvement and closer analysis.
DermaFreeze's performance in Arizona's Topical category showcases both its strengths and areas for potential growth. The brand's ability to hold onto its 7th position amidst fluctuating sales figures speaks to its established presence and consumer loyalty within the market. However, the sales dip in January 2024, followed by a gradual recovery, points towards underlying challenges that may need addressing to capitalize on growth opportunities fully. This performance trajectory offers valuable insights into market dynamics and consumer preferences, highlighting the importance of strategic adjustments and innovation in sustaining and enhancing market position.
Competitive Landscape
In the competitive landscape of the topical cannabis market in Arizona, DermaFreeze has maintained a consistent position, ranking 7th from December 2023 through March 2024. This stability in rank, however, masks the underlying dynamics of its sales performance and its standing relative to competitors. Notably, Müv / MUV has shown a more volatile rank but ultimately increased its sales, moving from 6th to 5th place and demonstrating significant sales growth in March. In contrast, Gramz, which ranked higher than DermaFreeze in December, experienced a decline in both rank and sales, dropping to 6th place with a noticeable decrease in sales by March. Halo Infusions remained steady in the 8th position, yet its sales surged, potentially indicating a future challenge to DermaFreeze's rank. Meanwhile, CBD Wellness saw a decline in rank and a significant drop in sales, moving from 9th to 9th place with the lowest sales among the mentioned competitors in March. This analysis suggests that while DermaFreeze has maintained its rank, the shifting dynamics among its competitors, particularly the sales growth of Halo Infusions and the volatility of Müv / MUV, could pose challenges to its market position in the near future.
Notable Products
In Mar-2024, the top-performing product for DermaFreeze was CBD/THC 5:1 Advanced Topical Nano-Gel (500mg CBD, 100mg THC) within the Topical category, maintaining its number one rank consistently from Dec-2023 through Mar-2024. This product saw sales of 931 units in March, indicating a stable demand throughout the period. There were no other products from DermaFreeze mentioned for comparison, highlighting the Nano-Gel's dominance in the lineup. The sales figures suggest a slight increase from February to March, showing a positive trend. This single data point emphasizes the product's strong market presence and sustained consumer interest over several months.
Top Selling Cannabis Brands
